ArticleFrontiers in public health2025
Use of machine learning models to predict mortality in dialysis patients.
Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Validation of online clearance monitoring and machine learning-based prediction of dialysis adequacy in Vietnamese hemodialysis patients: a cross-sectional study.BMC nephrology · 2026Article
- Machine learning-based prediction of bronchiolitis in children under two years: a multicenter study within a single metropolitan area.BMC infectious diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Mortality among maintenance hemodialysis patients remains high, and traditional statistical models often fail to capture complex clinical relationships. This study aimed to systematically develop, compare, and validate 19 machine learning algorithms for predicting all-cause mortality in maintenance hemodialysis patients. Methods: This retrospective study included data from 538 maintenance hemodialysis patients (2018.1-2023.12), with 70% used for training and 30% for testing. Each model underwent hyperparameter optimization based on three performance metrics (accuracy, F1-score, and ROC Area Under the Curve [AUC]) to evaluate the impact of different clinical priorities. Results: Gradient boosting models demonstrated consistent superiority, with performance outcomes highly sensitive to the selected optimization target. XGBoost optimized for accuracy achieved an F1 score of 0.683 and a ROC AUC of 0.899. AdaBoost optimized for F1 score attained the highest ROC AUC of 0.903 and an F1 score of 0.682. AdaBoost also demonstrated robust performance across optimization strategies, suggesting its suitability for clinical implementation where balanced risk prediction is essential. Conclusion: A systematic ML framework can yield tailored, high-performing models for mortality risk stratification in maintenance hemodialysis patients, with significant potential to enhance identification and management of high-risk individuals in clinical practice. Clinical trial number Registry: Chinese Clinica Trial Registry (ChiCTR), TRN:ChiCTR2500103960, Registration date: 9 June 2025.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.